Join
Live feed
·
INSIDERFilingvia Quantisnow
Evelo Biosciences Inc. logo

Gill Simba sold $7,864 worth of shares (1,996 units at $3.94) and converted options into 15,000 shares, increasing direct ownership by 346% to 16,758 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EVLO (Evelo Biosciences Inc.) and more on Quantisnow.